InvestorsHub Logo
Post# of 596859
Next 10
Followers 972
Posts 383062
Boards Moderated 5
Alias Born 06/24/2011

Re: None

Tuesday, 09/12/2017 12:26:23 PM

Tuesday, September 12, 2017 12:26:23 PM

Post# of 596859
$PSID Including its predecessor companies, ExcitePCR has received over $35 million since 2004 from the U.S. Department of Homeland Security (DHS) and other U.S. governmental entities to design, develop and produce rapid pathogen detection solutions. This foundational work has allowed ExcitePCR to produce significant breakthroughs in the world of PCR-based solutions for rapidly and accurately identifying the presence of countless biological threats anywhere in the world, including the typically time-consuming act of sample preparation, all within 30 minutes or less. ExcitePCR has now begun work to commercialize its FireflyDX technologies that Lawrence Livermore National Laboratory says have no known competition. PositiveID’s ExcitePCR Subsidiary to Hold Press Conference Announcing Lawrence Livermore National Report on its FireflyDX
https://finance.yahoo.com/news/positiveid-excitepcr-subsidiary-hold-press-120000070.html During the Press Conference, ExcitePCR will summarize its multiyear history in designing, developing and producing automated biohazard detection for U.S. governmental agencies and military organizations, as well as showcase its forthcoming FireflyDX-Portable™ pathogen detection system and select details from the report produced by LLNL for the company.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.